✦ LIBER ✦

Cerebrospinal fluid levels of chromogranin A in the treatment-naïve early stage Parkinson’s disease: a pilot study

✍ Scribed by Michaela Kaiserová, Hana Přikrylová Vranová…

Book ID: 120919166
Publisher: Springer
Year: 2013
Tongue: English
Weight: 189 KB
Volume: 120
Category: Article
ISSN: 1435-1463
DOI: 10.1007/s00702-013-1020-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Comparative Study on Neurochemistry of

A Comparative Study on Neurochemistry of Cerebrospinal Fluid in Advanced Parkinson's Disease

✍ H. Liu; R.P. Iacono; T. Schoonenberg; S. Kuniyoshi; J. Buchholz 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Cerebrospinal Fluid Biomarkers of Alzhei

Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in Chinese Patients: A Pilot Study

✍ Shea, Y. F.; Chu, L.-W.; Zhou, L.; Li, W.-M.; Lin, O. Y.; Chan, M. N. Y.; Xu, A. 📂 Article 📅 2013 🏛 SAGE Publications 🌐 English ⚖ 158 KB

1.018 Loss of thalamic serotonin transpo

1.018 Loss of thalamic serotonin transporters in early-stage, drug-naïve Parkinson's disease patients is associated with tremor: A [123I]β-CIT SPECT study

✍ V. Caretti; D. Stoffers; A. Winogrodzka; I.U. Isaias; G. Costantino; G. Pezzoli; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

1.270 Loss of thalamic serotonin transpo

1.270 Loss of thalamic serotonin transporters in early-stage, drug-naïve Parkinson's disease patients is associated with tremor: A [123I]β-CIT SPECT study

✍ V. Caretti; D. Stoffers; A. Winogrodzka; I.U. Isaias; G. Costantino; G. Pezzoli; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Tolerability of isradipine in early Park

Tolerability of isradipine in early Parkinson's disease: A pilot dose escalation study

✍ Tanya Simuni; Emily Borushko; Michael J. Avram; Scott Miskevics; Audrey Martel; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 958 KB

## Abstract Recent data suggests that isradipine, a dihydropyridine calcium channel blocker, is neuroprotective in preclinical models of parkinsonism. Isradipine has not been systematically studied in patients with Parkinson's disease (PD). The aim of this study was to evaluate safety and tolerabil

The use of famotidine in the treatment o

The use of famotidine in the treatment of Parkinson's disease: a pilot study

✍ S. P. Molinari; R. Kaminski; A. Di Rocco; M. D. Yahr 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 303 KB